Trial Profile
A phase II study investigating the effect of combination of docetaxel and temsirolimus in advanced castration resistant prostate cancer patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Temsirolimus (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Dec 2015 New trial record